- Home
- MOLN vs TCX Comparison
MOLN vs TCX Comparison
Compare MOLN & TCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- TCX
- Stock Information
- Founded
- MOLN 2004
- TCX 1992
- Country
- MOLN Switzerland
- TCX Canada
- Employees
- MOLN N/A
- TCX N/A
- Industry
- MOLN
- TCX EDP Services
- Sector
- MOLN
- TCX Technology
- Exchange
- MOLN Nasdaq
- TCX Nasdaq
- Market Cap
- MOLN 192.4M
- TCX 179.2M
- IPO Year
- MOLN 2021
- TCX 1996
- Fundamental
- Price
- MOLN $5.04
- TCX $15.53
- Analyst Decision
- MOLN
- TCX
- Analyst Count
- MOLN 0
- TCX 0
- Target Price
- MOLN N/A
- TCX N/A
- AVG Volume (30 Days)
- MOLN 5.7K
- TCX 23.4K
- Earning Date
- MOLN 03-13-2025
- TCX 02-13-2025
- Dividend Yield
- MOLN N/A
- TCX N/A
- EPS Growth
- MOLN N/A
- TCX N/A
- EPS
- MOLN N/A
- TCX N/A
- Revenue
- MOLN $7,105,397.00
- TCX $356,135,000.00
- Revenue This Year
- MOLN N/A
- TCX $8.16
- Revenue Next Year
- MOLN $29.41
- TCX N/A
- P/E Ratio
- MOLN N/A
- TCX N/A
- Revenue Growth
- MOLN N/A
- TCX 7.50
- 52 Week Low
- MOLN $3.32
- TCX $14.50
- 52 Week High
- MOLN $12.70
- TCX $26.48
- Technical
- Relative Strength Index (RSI)
- MOLN 41.97
- TCX 41.13
- Support Level
- MOLN $5.22
- TCX $14.50
- Resistance Level
- MOLN $5.35
- TCX $16.58
- Average True Range (ATR)
- MOLN 0.12
- TCX 0.57
- MACD
- MOLN -0.03
- TCX -0.09
- Stochastic Oscillator
- MOLN 0.00
- TCX 39.31
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About TCX Tucows Inc.
Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains.